No increase in acute MI with selective COX-2 inhibitors

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2003年 / 947-948卷 / 1期
关键词：
Acute Myocardial Infarction; Celecoxib; Naproxen; Rofecoxib; Nonselective NSAID;
D O I：
10.2165/00128415-200309470-00011
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：5 / 5
相关论文
共 50 条
  • [1] Clinical pharmacology of selective COX-2 inhibitors
    Capone, ML
    Tacconelli, S
    Sciulli, MG
    Patrignani, P
    INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2003, 16 (02) : 49 - 58
  • [2] Perception of risk: the state of COX-2 selective inhibitors.
    Simon L.S.
    Strand V.
    Current Rheumatology Reports, 2005, 7 (3) : 163 - 166
  • [3] Are selective COX-2 inhibitors nephrotoxic?
    Perazella, MA
    Eras, J
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 35 (05) : 937 - 940
  • [4] Effect of the selective COX-2 inhibitors, celecoxib and rofecoxib in rat acute models of inflammation
    Pinheiro, RM
    Calixto, JB
    INFLAMMATION RESEARCH, 2002, 51 (12) : 603 - 610
  • [5] COX-2 inhibitors in rheumatoid arthritis
    Sundy J.S.
    Current Rheumatology Reports, 2001, 3 (1) : 86 - 91
  • [6] COX-2 inhibitors and other NSAIDs linked to MI hospitalisation
    Reactions Weekly, 2005, 1059 (1) : 4 - 4
  • [7] The brand new selective COX-2 inhibitors NSAIDs.
    Cano, DL
    Rodríguez, BG
    Domínguez, YT
    Delgado, PH
    Esteban, JMH
    Gutiérrez, JMH
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 1999, 91 (08) : 598 - 598
  • [8] Reduction in the risk of human breast cancer by selective cyclooxygenase-2 (COX-2) inhibitors
    Randall E Harris
    Joanne Beebe-Donk
    Galal A Alshafie
    BMC Cancer, 6
  • [9] COX-1 and COX-2 inhibitors
    Hawkey, CJ
    BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2001, 15 (05) : 801 - 820
  • [10] Contest between the COX-2 inhibitors continues
    Reactions Weekly, 2000, 815 (1) : 3 - 4
12345